Novo Nordisk is a global healthcare company with an 80-year history of innovation and achievement in diabetes care.  Novo Nordisk manufactures and markets a comprehensive portfolio of insulin analogs and delivery systems.  Novo Nordisk also has a leading position within such areas as hemostasis and growth hormone therapy.